Hormone Therapy Linked to Autoimmune Disease Risk in Postmenopausal Women
A recent study presented at the annual meeting of the Menopause Society found that hormone therapy (HT) use is associated with an increased incidence and risk for developing autoimmune disease in postmenopausal women.
- HT users had a higher incidence of autoimmune disease at 5 years (6.7% vs 5.3%) and 10 years (8.6% vs 6.7%) compared to non-HT users.
- The study found significant increases in risk for all autoimmune diseases except Graves disease and hepatitis.
Among postmenopausal women, hormone therapy (HT) use is associated with an increased incidence and risk for developing autoimmune disease.
The study, conducted by Ameera Syed and colleagues, included 889,413 postmenopausal women in both the HT and non-HT cohorts after propensity score-matching.
Author's summary: Hormone therapy increases autoimmune disease risk in postmenopausal women.
More News
- Loss to Bucks stunk, but Warriors' Jimmy Butler knows key to returning to 'flowers and daisies'
- MacKenzie Scott gives record $50M to Virginia State University - Virginia Business
- Flyers flying under the radar — and deserve a packed house again | NorthPennNow
- Economy stumbles again, but not enough to spur more BoC cuts - CMT News
- 'Days of Our Lives' Spoilers (Nov. 3-7): A Few Discoveries and an Adoption
- Riley Green & Ella Langley Notch Second Top 10 Together on Country Airplay Chart
- Bam Adebayo's evolution into 'three-level scorer' starts with Heat's new offense
- 'Love Island's' Huda Mustafa Apologizes After Laughing At Racist Slur Hurled Towards Olandria Carthen
- No Giannis, No Problem — Bucks Take Down Warriors as Antetokounmpo Steals the Show in Minion Costume
- Coloradans scramble for help as SNAP suspension looms and food banks ‘just don’t have enough’